[Therapeutic defibrination with ancrod (author's transl)].
D000328:Adult; D000368:Aged; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001783:Blood Flow Velocity; D001809:Blood Viscosity / Q000187:drug effects; D057487:Enzyme Therapy; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D005528:Foot / Q000098:blood supply; D006460:Hemolysin Proteins / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D012039:Regional Blood Flow; D012911:Snakes; D014688:Venoms / Q000627:therapeutic use*
D000925:Anticoagulants; D006460:Hemolysin Proteins; D014688:Venoms; D005337:Fibrin
Therapeutische Defibrinierung mit Ancrod.